Investigational Drug Details
| Drug ID: | D491 |
| Drug Name: | Methyl-D9-choline |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | DB12628 |
| DrugBank Description: | Methyl-D9-choline is under investigation in clinical trial NCT01807910 (ER Stress in NAFLD). |
| PubChem ID: | -- |
| CasNo: | 50673-41-1 |
| Repositioning for NAFLD: | No |
| SMILES: | [2H]C([2H])([2H])[N+](CCO)(C([2H])([2H])[2H])C([2H])([2H])[2H] |
| Structure: |
|
| InChiKey: | OEYIOHPDSNJKLS-GQALSZNTSA-N |
| Molecular Weight: | 113.227 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 1 withdrawn (NCT01807910: The study was not funded) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0155 | NCT01807910 | Early Phase 1 | Withdrawn | No Results Available | October 2013 | October 23, 2013 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|